We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLLY icon
1926
Holley
HLLY
$319M
$511K ﹤0.01%
142,773
+82,611
+137% +$322K
RILY icon
1927
BRC Group Holdings
RILY
$273M
$509K ﹤0.01%
+28,877
New +$743K
ERX icon
1928
CALL
Direxion Daily Energy Bull 2X ETF
ERX
$229M
$508K ﹤0.01%
+7,800
New +$532K
PANW icon
1929
Palo Alto Networks
PANW
$259B
$507K ﹤0.01%
2,994
-715,006
-100% -$107M
MTSI icon
1930
MACOM Technology Solutions
MTSI
$20.1B
$505K ﹤0.01%
4,532
-12,581
-74% -$1.28M
VCR icon
1931
Vanguard Consumer Discretionary ETF
VCR
$5.92B
$500K ﹤0.01%
+1,600
New +$490K
CLDT
1932
Chatham Lodging
CLDT
$643M
$500K ﹤0.01%
+58,629
New +$527K
CVRX icon
1933
CVRx
CVRX
$129M
$495K ﹤0.01%
+41,265
New +$475K
GPGI
1934
GPGI Inc
GPGI
$4.12B
$492K ﹤0.01%
87,129
-40,996
-32% -$227K
IMRX icon
1935
Immuneering
IMRX
$282M
$492K ﹤0.01%
+384,075
New +$631K
TLK icon
1936
Telkom Indonesia
TLK
$14.3B
$492K ﹤0.01%
+26,287
New +$503K
PPH icon
1937
VanEck Pharmaceutical ETF
PPH
$967M
$491K ﹤0.01%
+5,372
New +$480K
GNW icon
1938
Genworth Financial
GNW
$3.79B
$491K ﹤0.01%
+81,269
New +$506K
GBTG icon
1939
American Express Global Business Travel
GBTG
$4.91B
$489K ﹤0.01%
+74,161
New +$455K
EPAC icon
1940
Enerpac Tool Group
EPAC
$1.78B
$486K ﹤0.01%
12,734
-17,397
-58% -$645K
TUYA
1941
Tuya Inc
TUYA
$1.01B
$484K ﹤0.01%
282,836
+6,081
+2% +$11K
LTH icon
1942
Life Time Group Holdings
LTH
$9.74B
$483K ﹤0.01%
+25,677
New +$406K
BTBT icon
1943
Bit Digital
BTBT
$477M
$483K ﹤0.01%
+151,920
New +$371K
ALGN icon
1944
Align Technology
ALGN
$12B
$483K ﹤0.01%
2,000
-9,052
-82% -$2.52M
PNR icon
1945
Pentair
PNR
$10.2B
$482K ﹤0.01%
6,292
-62,672
-91% -$5.05M
SHEN icon
1946
Shenandoah Telecom
SHEN
$637M
$480K ﹤0.01%
+29,424
New +$474K
VTSI icon
1947
VirTra
VTSI
$35.5M
$480K ﹤0.01%
+62,460
New +$718K
CINT icon
1948
CI&T Inc
CINT
$409M
$479K ﹤0.01%
92,114
+65,457
+246% +$280K
VTS icon
1949
Vitesse Energy
VTS
$636M
$478K ﹤0.01%
20,181
-3,016
-13% -$71.7K
QCOM icon
1950
PUT
Qualcomm
QCOM
$179B
$478K ﹤0.01%
2,400
-100
-4% -$18.9K

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.